Medical Community Urges Stricter Drug Monitoring After Cough Syrup Tragedy

Published: October 09, 2025 | Category: Real Estate Pune
Medical Community Urges Stricter Drug Monitoring After Cough Syrup Tragedy

PUNE: The recent incident where ‘Coldrif’ cough syrup has been linked to the deaths of 19 children in Madhya Pradesh (MP) and Rajasthan, and the subsequent arrest of Dr Praveen Soni, a paediatrician from MP, has sent shockwaves through the medical fraternity, intensifying fear and uncertainty among doctors across the country.

Members of the Indian Medical Association (IMA), Pune Chapter, have expressed deep concern, stating that doctors prescribe medicines in good faith for their patients’ recovery and have no control over the manufacturing quality or composition or monitoring of the drugs available in the market. However, they are still at legal and professional risk.

On Thursday, a meeting was held by members of the IMA Pune Chapter to discuss the issue of spurious, substandard, and unsafe drugs, and the urgent need for stricter monitoring by the Food and Drug Administration (FDA).

“Doctors are now fearful. Our role is to treat patients, but such incidents make us question the safety of the drugs we prescribe. Despite having no control over it, we can still face unfortunate legal action,” said Dr Sunil Ingale, president of the IMA Pune Chapter.

During the Thursday meeting, doctors also emphasized the need for stricter enforcement of the rule prohibiting over-the-counter (OTC) sales of prescription medicines such as cough syrups. “Many people buy these syrups without consulting a doctor. In most cases, common colds resolve without medication. These drugs should be sold only with a valid prescription,” said Dr Sanjay Patil, national secretary, Hospital Board of India.

The IMA Pune Chapter has also called for a comprehensive review of the drug approval and monitoring process to ensure that such tragedies do not occur in the future. They have urged the FDA to take immediate action to strengthen its regulatory mechanisms and to ensure that all drugs available in the market meet the highest standards of safety and quality.

The incident has not only raised concerns about the safety of over-the-counter medications but has also highlighted the need for better communication and collaboration between healthcare providers, regulatory bodies, and the pharmaceutical industry. The medical community is united in their call for stricter regulations and better enforcement to protect the health and well-being of patients.

In the wake of this tragedy, the IMA Pune Chapter has also initiated a campaign to educate the public about the risks associated with self-medication and the importance of consulting a healthcare professional before taking any medication. They are working closely with local pharmacies to ensure that prescription drugs are sold only with a valid prescription and that patients are provided with the necessary information to make informed decisions about their health.

The medical community remains committed to working with the FDA and other stakeholders to ensure that such incidents are prevented in the future. The health and safety of patients remain the top priority, and they are determined to take all necessary steps to achieve this goal.

Stay Updated with GeoSquare WhatsApp Channels

Get the latest real estate news, market insights, auctions, and project updates delivered directly to your WhatsApp. No spam, only high-value alerts.

GeoSquare Real Estate News WhatsApp Channel Preview

Never Miss a Real Estate News Update — Get Daily, High-Value Alerts on WhatsApp!

Frequently Asked Questions

1. What is the recent incident that has raised concerns about drug safety in India?
The recent incident involves the deaths of 19 children in Madhya Pradesh and Rajasthan, which have been linked to a contaminated cough syrup called 'Coldrif'. This has led to increased calls for stricter drug monitoring and regulation.
2. What is the Indian Medical Association's stance on the issue?
The Indian Medical Association (IMA) has expressed deep concern and is calling for stricter monitoring of drugs by the FDA. They are also emphasizing the need for better enforcement of rules prohibiting over-the-counter sales of prescription medicines.
3. Why are doctors concerned about the legal and professional risks associated with prescribing medicines?
Doctors are concerned because they prescribe medicines in good faith but have no control over the manufacturing quality or composition of the drugs. Despite this, they can still face legal action if the drugs they prescribe cause harm.
4. What measures are being proposed to prevent such incidents in the future?
The IMA is calling for a comprehensive review of the drug approval and monitoring process, stricter enforcement of rules prohibiting over-the-counter sales of prescription medicines, and better communication and collaboration between healthcare providers, regulatory bodies, and the pharmaceutical industry.
5. What is the IM
Pune Chapter doing to educate the public about the risks of self-medication? A: The IMA Pune Chapter has initiated a campaign to educate the public about the risks associated with self-medication and the importance of consulting a healthcare professional before taking any medication. They are also working closely with local pharmacies to ensure that prescription drugs are sold only with a valid prescription.